BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7533703)

  • 21. Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension.
    Kuschnir E; Bendersky M; Resk J; Pañart MS; Guzman L; Plotquin Y; Grassi G; Mancia G; Wagener G
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):300-5. PubMed ID: 14716221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
    Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
    Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underestimation of 24-hour hypotensive efficacy of nifedipine GITS versus enalapril: ambulatory recording as an adjunct to clinical blood pressure measurement.
    Schulte KL; Lenz T; Fischer M; Meyer-Sabellek W; Gotzen R
    Blood Press; 2000; 9(4):221-6. PubMed ID: 11055475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
    Houston MC; Olafsson L; Burger MC
    Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
    Taddei S; Omboni S; Ghiadoni L; Caiazza A; Fogari R; Innocenti P; Porcellati C; Giovannetti R; Corradi L; Mancia G; Salvetti A
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):579-85. PubMed ID: 12658059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
    Wurdeman RL; Mooss AN; Mohiuddin SM; Lucas BD; Ryschon KL; Hilleman DE
    Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
    Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
    Am J Cardiol; 1989 Sep; 64(11):65F-69F. PubMed ID: 2782273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR; Bravo EL; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Bravo EL; Krakoff LR; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses.
    Kjeldsen SE; Cha G; Villa G; Mancia G;
    J Clin Pharmacol; 2016 Sep; 56(9):1120-9. PubMed ID: 26829251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension.
    Fogari R; Mugellini A; Zoppi A; Corradi L; Rinaldi A; Derosa G; Preti P
    Am J Hypertens; 2003 Jul; 16(7):596-9. PubMed ID: 12850395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I; Stokke HP
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effects of a new sustained-release formulation of nifedipine.
    Zachariah PK; Schwartz GL; Sheps SG; Schirger A; Carlson CA; Moore AG
    J Clin Pharmacol; 1990 Nov; 30(11):1012-9. PubMed ID: 2243148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT).
    Toal CB; Mahon WA; Barnes C; Burelle D
    Clin Ther; 1997; 19(5):924-35. PubMed ID: 9385481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nifedipine GITS in Asians with hypertension: results of a post-marketing surveillance study in China.
    Runlin G; Junren Z; Guozhang L; Weizhong Z; Tingjie Z; Ningling S; Landen H
    Clin Drug Investig; 2007; 27(8):565-72. PubMed ID: 17638397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of antihypertensive efficacy after missed doses: comparison of amlodipine and nifedipine gastrointestinal therapeutic system.
    Elliott HL; Elawad M; Wilkinson R; Singh SP
    J Hypertens; 2002 Feb; 20(2):333-8. PubMed ID: 11821720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group.
    Parmley WW; Nesto RW; Singh BN; Deanfield J; Gottlieb SO
    J Am Coll Cardiol; 1992 Jun; 19(7):1380-9. PubMed ID: 1350596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.